Target intelligence / Profile preview

RNA, U6 small nuclear 926, pseudogene (RNU6-926P)

Target
RNU6-926P
Molecular classification
pseudogene, non-coding RNA
01

Overview

RNU6-926P (RNA, U6 small nuclear 926, pseudogene) is a member of the large family of U6 small nuclear RNA-derived pseudogenes found in the human genome. U6 small nuclear RNA (U6 snRNA) is a highly conserved non-coding RNA essential for pre-mRNA splicing as part of the spliceosome complex[3][1]. However, the RNU6-926P gene itself is a pseudogene, meaning it is a non-functional copy of the U6 snRNA gene that is incapable of producing the functional RNA and thus does not contribute directly to spliceosome activity. Pseudogenes are typically the result of gene duplication or retrotransposition events and, while most lack protein-coding function, they can sometimes participate in gene regulation via non-coding mechanisms (e.g., serving as competitive endogenous RNAs, decoys for miRNA, or sources of regulatory RNAs)[4]. There is no evidence suggesting RNU6-926P is a therapeutic target, nor is there indication of its involvement in disease or interaction with any drugs.

Other names
RNU6-926PRNA, U6 small nuclear 926, pseudogene
02

Mechanism of action

None

03

Biological functions

No confirmed biological function as functional geneas with other pseudogenes, potential roles include regulatory non-coding RNA mechanisms such as competing endogenous RNA, miRNA decoy, or source of siRNA (extrapolated from general pseudogene literature)[4]
04

Disease associations

None directly associatedin general, some pseudogenes are implicated in disease via regulatory effects, but no evidence links RNU6-926P directly to disease[4]
05

Safety considerations

None
06

Interacting drugs

None reported
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, U6 small nuclear 926, pseudogene (RNU6-926P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 926, pseudogene (RNU6-926P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call